How Effective Are Wegovy and Mounjaro for Weight Loss?
Does Wegovy Work As Well As Mounjaro for Prescription Weight Loss?
When comparing prescription weight loss treatments, understanding that Wegovy and Mounjaro work through different mechanisms is crucial for making an informed decision. Wegovy (semaglutide) is a GLP-1 receptor agonist that mimics your body's natural fullness hormone, designed to reduce appetite and promote satiety after smaller meals. Mounjaro (tirzepatide) is a dual-action treatment targeting both GIP and GLP-1 receptors, offering a different approach to weight management through multiple hormonal pathways.
Both treatments are prescription-only medicines requiring clinical assessment to ensure suitability based on your BMI and medical history. The question of whether Wegovy works as well as Mounjaro cannot be answered directly through head-to-head comparison, as clinical trials used different study designs, populations, and endpoints. Your prescriber at EverydayMeds can evaluate which mechanism aligns better with your individual weight loss goals and medical profile, ensuring you receive the most appropriate treatment for your circumstances.
Wegovy and Mounjaro Pricing: Complete Cost Breakdown
Understanding the investment required for prescription weight loss treatment helps you plan effectively for your weight management journey. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. Our Intro Duo bundle (0.25mg & 0.5mg) provides your first 8 weeks of treatment for £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) covers 12 weeks for £369.99. These bundles offer convenience through fewer orders and Reliable Supply continuity.
Mounjaro pricing follows a different structure, with costs varying according to the dose escalation schedule recommended by your prescriber. Both treatments qualify for discount codes applied at checkout - use FIRST40 for new customers or DOSE25 for returning customers to access our competitive pricing. The total investment depends on your prescribed dose schedule and treatment duration, with most patients requiring long-term treatment for sustained weight management results alongside a reduced-calorie diet and increased physical activity.
Clinical Evidence: How Well Does Wegovy Work Compared to Mounjaro?
Wegovy's efficacy is demonstrated through the comprehensive STEP clinical trial programme, where patients taking semaglutide alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks in STEP 1, compared to 2.4% with placebo. The STEP 5 trial showed sustained weight loss of 15.2% at 2 years, whilst the recent SELECT trial demonstrated a 20% reduction in major cardiovascular events. These results establish Wegovy as an effective prescription weight loss treatment when used as directed.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, showing significant weight loss results through its dual GIP/GLP-1 receptor targeting mechanism. However, directly comparing whether Wegovy works as well as Mounjaro requires understanding that different trial methodologies, patient populations, and study durations make head-to-head efficacy comparisons inappropriate. Both treatments have demonstrated substantial weight loss potential when prescribed appropriately and used alongside lifestyle modifications.
Understanding How Wegovy Works for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking incretin hormones naturally produced in your intestines following meals. This mechanism works on appetite centres in your brain, potentially reducing food cravings and promoting feelings of fullness after consuming smaller portions. The treatment may also slow gastric emptying, contributing to prolonged satiety between meals and supporting adherence to reduced-calorie eating patterns. Unlike traditional appetite suppressants, Wegovy works through your body's existing hormonal pathways rather than artificial stimulation. This natural approach to appetite regulation forms the foundation of Wegovy's weight management mechanism, supporting sustainable lifestyle changes when combined with dietary modifications and increased physical activity.
Starting Your Wegovy Treatment: Complete Process
Beginning prescription weight loss treatment at EverydayMeds starts with our 3-minute online clinical assessment, designed to evaluate your eligibility based on BMI requirements and medical history. Our GPhC-registered prescribers (#9012878) review your assessment within 3 working days (or 24 hours with express service), ensuring clinical safety and treatment appropriateness. Once approved, your Wegovy pen ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The dose escalation begins with 0.25mg weekly for 4 weeks, progressing systematically to your target maintenance dose. Our clinical team provides ongoing support throughout your weight management journey, ensuring optimal treatment outcomes and addressing any questions about your prescribed regimen.
Storage Requirements and Practical Considerations
Proper storage maintains Wegovy's effectiveness throughout your treatment course, requiring refrigeration at 2-8°C before first use to preserve the semaglutide formulation. Once removed from refrigeration, Wegovy remains stable for up to 6 weeks at room temperature below 30°C, offering superior travel convenience compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design provides intuitive self-administration with pre-measured doses, eliminating guesswork during your weekly injections. Dose escalation follows a mandatory schedule designed to minimise side effects whilst achieving therapeutic effectiveness - you cannot skip escalation steps or jump to higher doses prematurely. Each pen contains 4 doses for monthly supply, with clear dose counters ensuring accurate administration throughout your prescribed treatment period.
Prescription Weight Loss: Wegovy vs Mounjaro Decision Factors
Choosing between Wegovy and Mounjaro for prescription weight loss involves considering multiple factors beyond the question of whether Wegovy works as well as Mounjaro. Storage convenience favours Wegovy with its 6-week room temperature stability, particularly beneficial for frequent travellers or those with limited refrigeration access. The single GLP-1 mechanism of Wegovy offers proven efficacy with well-established safety data from extensive clinical trials and real-world usage.
Mounjaro's dual GIP/GLP-1 approach provides a different therapeutic strategy that may suit patients who haven't achieved desired results with single-mechanism treatments. Both treatments require commitment to lifestyle changes including reduced-calorie diet and increased physical activity for optimal results. Your prescriber can evaluate your medical history, previous weight loss attempts, and individual circumstances to recommend the most suitable option for your prescription weight loss journey.
Start Your Prescription Weight Loss Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds following clinical assessment, with your prescriber helping determine which treatment aligns with your weight management goals. Our streamlined ordering process ensures rapid access to prescription weight loss treatment, from initial assessment through next-day delivery of your prescribed medication. New customers can use code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 to access competitive pricing across our complete range. Don't wait to begin your weight management journey - complete your clinical assessment today and take the first step towards sustainable weight loss. Visit https://everydaymeds.co.uk/collections/wegovy to explore treatment options and begin your prescription weight loss programme with confidence.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
